Denali Therapeutics Reports Third Quarter 2024 Financial Results and Business Highlights
Provided By GlobeNewswire
Last update: Nov 6, 2024
SOUTH SAN FRANCISCO, Calif., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (Nasdaq: DNLI) today reported financial results for the third quarter ended September 30, 2024, and provided business highlights.
Read more at globenewswire.com
